These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Expanded clinical evaluation of lovastatin (EXCEL) study results: IV. Additional perspectives on the tolerability of lovastatin. Dujovne CA; Chremos AN; Pool JL; Schnaper H; Bradford RH; Shear CL; Higgins J; Downton M; Franklin FA; Nash DT Am J Med; 1991 Jul; 91(1B):25S-30S. PubMed ID: 1831006 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of lovastatin in 3390 women with moderate hypercholesterolemia. Bradford RH; Downton M; Chremos AN; Langendörfer A; Stinnett S; Nash DT; Mantell G; Shear CL Ann Intern Med; 1993 Jun; 118(11):850-5. PubMed ID: 8480959 [TBL] [Abstract][Full Text] [Related]
6. Lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia. A multicenter study. Havel RJ; Hunninghake DB; Illingworth DR; Lees RS; Stein EA; Tobert JA; Bacon SR; Bolognese JA; Frost PH; Lamkin GE Ann Intern Med; 1987 Nov; 107(5):609-15. PubMed ID: 3662274 [TBL] [Abstract][Full Text] [Related]
7. Expanded clinical evaluation of lovastatin (EXCEL) study: design and patient characteristics of a double-blind, placebo-controlled study in patients with moderate hypercholesterolemia. Bradford RH; Shear CL; Chremos AN; Dujovne C; Franklin FA; Hesney M; Higgins J; Langendörfer A; Pool JL; Schnaper H Am J Cardiol; 1990 Sep; 66(8):44B-55B. PubMed ID: 2206036 [TBL] [Abstract][Full Text] [Related]
8. A multicenter comparison of lovastatin and probucol for treatment of severe primary hypercholesterolemia. The Lovastatin Study Group IV. Am J Cardiol; 1990 Sep; 66(8):22B-30B. PubMed ID: 2206033 [TBL] [Abstract][Full Text] [Related]
9. Treatment of familial hypercholesterolemia in children and adolescents: effect of lovastatin. Canadian Lovastatin in Children Study Group. Lambert M; Lupien PJ; Gagné C; Lévy E; Blaichman S; Langlois S; Hayden M; Rose V; Clarke JT; Wolfe BM; Clarson C; Parsons H; Stephure DK; Potvin D; Lambert J Pediatrics; 1996 May; 97(5):619-28. PubMed ID: 8628597 [TBL] [Abstract][Full Text] [Related]
10. Quetiapine : A Review of its Use in Schizophrenia. Gunasekara NS; Spencer CM CNS Drugs; 1998 Apr; 9(4):325-40. PubMed ID: 27521016 [TBL] [Abstract][Full Text] [Related]
11. Lovastatin for the adjunctive treatment of schizophrenia: a preliminary randomized double-blind placebo-controlled trial. Ghanizadeh A; Rezaee Z; Dehbozorgi S; Berk M; Akhondzadeh S Psychiatry Res; 2014 Nov; 219(3):431-5. PubMed ID: 25017614 [TBL] [Abstract][Full Text] [Related]
12. Expanded Clinical Evaluation of Lovastatin (EXCEL) study results: two-year efficacy and safety follow-up. Bradford RH; Shear CL; Chremos AN; Dujovne CA; Franklin FA; Grillo RB; Higgins J; Langendorfer A; Nash DT; Pool JL Am J Cardiol; 1994 Oct; 74(7):667-73. PubMed ID: 7942524 [TBL] [Abstract][Full Text] [Related]
13. A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia. The Lovastatin Study Group III. JAMA; 1988 Jul; 260(3):359-66. PubMed ID: 2898027 [TBL] [Abstract][Full Text] [Related]
14. Expanded clinical evaluation of lovastatin (EXCEL) study results. II. Assessment of the human lens after 48 weeks of treatment with lovastatin. Laties AM; Shear CL; Lippa EA; Gould AL; Taylor HR; Hurley DP; Stephenson WP; Keates EU; Tupy-Visich MA; Chremos AN Am J Cardiol; 1991 Mar; 67(6):447-53. PubMed ID: 1998274 [TBL] [Abstract][Full Text] [Related]
15. Lovastatin 5-year safety and efficacy study. Lovastatin Study Groups I through IV. Arch Intern Med; 1993 May; 153(9):1079-87. PubMed ID: 8481075 [TBL] [Abstract][Full Text] [Related]
17. Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study. Pedersen TR; Berg K; Cook TJ; Faergeman O; Haghfelt T; Kjekshus J; Miettinen T; Musliner TA; Olsson AG; Pyörälä K; Thorgeirsson G; Tobert JA; Wedel H; Wilhelmsen L Arch Intern Med; 1996 Oct; 156(18):2085-92. PubMed ID: 8862101 [TBL] [Abstract][Full Text] [Related]
18. Frequency of myopathy in patients receiving lovastatin. Wortmann RL; Tipping RW; Levine JG; Melin JM Am J Cardiol; 2005 Apr; 95(8):983-5. PubMed ID: 15820170 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the short term efficacy and tolerability of lovastatin and simvastatin in the management of primary hypercholesterolemia. Frohlich J; Brun LD; Blank D; Campeau L; Crockford P; Curnew G; Dafoe W; Davignon J; Dufour R; Emery G Can J Cardiol; 1993 Jun; 9(5):405-12. PubMed ID: 8348392 [TBL] [Abstract][Full Text] [Related]
20. Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TEXCAPS): additional perspectives on tolerability of long-term treatment with lovastatin. Downs JR; Clearfield M; Tyroler HA; Whitney EJ; Kruyer W; Langendorfer A; Zagrebelsky V; Weis S; Shapiro DR; Beere PA; Gotto AM Am J Cardiol; 2001 May; 87(9):1074-9. PubMed ID: 11348605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]